• Tidak ada hasil yang ditemukan

Approval on the report of the Board of Directors for the fiscal y

N/A
N/A
Protected

Academic year: 2024

Membagikan "Approval on the report of the Board of Directors for the fiscal y"

Copied!
6
0
0

Teks penuh

(1)

Page 1 of 6

Meeting Results of the Ordinary General Assembly’s

Item (1): Approval on the report of the Board of Directors for the fiscal year ending on 31/12/2019.

Item (2): Approval on the company's auditors' report for the fiscal year ending on 31/12/2019.

Item (3): Approval on the financial statements for the fiscal year ending on 31/12/2019.

Item (4): Approval to absolve the Board of Directors members liability during the year ended 31/12/2019.

Item (5): Approval on appointing the company’s auditors from among the candidates based on the recommendation of the Audit Committee to examine, review and audit the financial statements for the second, third, fourth and annual quarter of the fiscal year 2020 and the first quarter of the fiscal year 2021 and determine their fees.

Item (6): Approval on the recommendation of the Board of Directors to appoint Mr. Khalid Abid Gama an independent member of the Board of Directors starting from the date of appointment on 25/11/1440 AH corresponding to 28/07/2019 AD to complete the current session of the Board on 07/03/2021 AD to replace Dr. Belal Talal Ghazzawi.

Item (7): Approval on the recommendation of the Board of Directors to appoint Mr. Khaled Abdullah AImass, representative of the National Health Insurance Company - Daman as a non-executive member of the Board of Directors starting from the date of appointment on 14/08/1441 AH corresponding to 07/04/2020 AD to complete the session of the Board until the end of the current session on 07/03/2021 to replace the previous member Mr. Michael Bitzer .

Item (8): Approval on the recommendation of the Board of Directors to appoint Mr. Khalid Abid Gama - Chairman of the Audit Committee as an independent member starting from the date of his appointment on 28/04/1441 AH corresponding to 25/12/2019 AD until the end of the current committee’s session on 07/03/2021 AD instead of Chairman of the Audit Committee, Dr. Bilal Talal Ghazzawi, provided that the appointment takes effect from the date of the recommendation decision issued on 08/04/1441 AH corresponding to 25/12/2019. This appointment comes in accordance with the Audit Committee’s regulations.

(2)

Page 2 of 6

Item (9): Approval on the recommendation of the Board of Directors to appoint Mr. Mr. Kinana Ghaleb Al-Sharif as an independent member of the Audit Committee from outside the Board, starting from the date of his appointment on 17/03/1441 AH corresponding to 14/11/2019 until the end of the current session of the Committee on 07/03/2021AD, to replace the member of the Audit Committee, Mr. Yasser Hussein Balkhi, provided that the appointment takes effect as of the date of the recommendation decision issued on 1441/03/17 AH corresponding to 14/11/2019 AD. This appointment comes in accordance with the Audit Committee’s regulations.

Item (10): Approval on the recommendation of the Board of Directors to appoint Mr. Sultan Mohammad Abdul Raouf as an independent member of the Audit Committee from outside the Board, starting from the date of his appointment on 29/07/1441 AH corresponding to 24/04/2020 AD until the end of the current committee’s session on 07/03/2021, to replace the member of the Audit Committee Mr.

Sulaiman Ahmed Abu Tayeh, provided that the appointment takes effect as of the date of the recommendation decision issued on 29/07/1441 AH corresponding to 24/04/2020 AD. This appointment comes in accordance with the Audit Committee’s regulations.

Item (11): Approval on the business and contracts concluded between the company and the company of Dr. Suleiman Abdel Qader Fakeeh Hospital and for which as a member of the Board of Directors, Dr.

Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year in the amount of 16,886,493 SR and this agreement does not have any preferential terms

Item (12): Approval on business and contracts concluded between the company and the company of Dr.

Suleiman Abdel Qader Fakeeh for Medical Education and for which a member of the Board of Directors Dr. Mazen Suleiman Abdel Qader Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 904,898 SR. This agreement does not have any preferential terms

Item (13): Approval on business and contracts concluded between the company and Al-Farabi

Distinguished Health Care Company, in which a member of the Board of Directors Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 2,072,475 SR. This agreement has no preferential terms

(3)

Page 3 of 6

Item (14): Approval on the business and contracts concluded between the company and the Arab Kameed Company Ltd., in which a member of the Board of Directors Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 140,134 SR. This agreement has no preferential terms

Item (15): Approval on the business and contracts concluded between the company and the company of Dr. Suleiman Fakeeh Center, in which a member of the Board of Directors, Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 437,197 SR, This agreement has no preferential terms

Item (16): Approval on the business and contracts concluded between the company and Dr. Mazen Suleiman Fakeeh Integrated Medical Company Limited, for which a member of the Board of Directors Dr.

Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 471,206 SR . This agreement has no preferential terms

Item (17): Approval on the business and contracts that will take place between the company and Khaled Al-Juffali Industrial Company Limited, in which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company employees for a period of one year, knowing that the business during the year 2019 amounted to 405,198 SR. This agreement has no preferential terms.

Item (18): Approval on business and contracts concluded between the company and Khalid Ahmed Al- Juffali Construction Company Limited and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 235,557 SR. This agreement has no preferential terms.

Item (19): Approval on business and contracts concluded between the company and Gap Corp Saudi Arabia Ltd. in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 190,017 SR. This agreement has no preferential terms.

Item (20): Approval on business and contracts concluded between the company and the Aoun Center for Speech and Hearing Assessment for Children and for which a member of the Board of Directors Mrs.

Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 743,045 SR. This agreement has no preferential terms.

(4)

Page 4 of 6

Item (21): Approval on business and contracts concluded between the company and Khaled Ahmed Al- Juffali Company and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 237,763 SR. This agreement has no Preferential terms .

Item (22): Approval on business and contracts concluded between the company and Lonsdale and Associates Insurance Brokerage Company, for which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 196,535 SR. This agreement has no preferential terms .

Item (23): Approval on the business and contracts that will take place between the company and Khaled Ahmed Al-Juffali Energy and Utilities Company Limited and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year, noting that the business during the year 2019 reached the value of 49,775 SR. This agreement has no preferential terms.

Item (24): Approval on the business and contracts concluded between the company and Khalid Ahmed Al-Juffali Holding Company, in which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 177,918 SR. This agreement has no preferential terms.

Item (25): Approval on business and contracts concluded between the company and Dahna International Marketing Company, in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 21,929 SR. This agreement has no preferential terms.

Item (26): Approval on the business and contracts concluded between the company and the International Medical Center, in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 26,276,783 SR. This agreement has no preferential terms.

Item (27): Approval on business and contracts concluded between the company and the First Clinic in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 1,688,644 SR. This agreement has no preferential terms.

(5)

Page 5 of 6

Item (28): Approval on works and contracts concluded between the company and the First X-rays in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 194,439 SR. This agreement has no preferential terms.

Item (29): Approval on business and contracts concluded between the company and the Akiyar International Company and for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 2,867,402 SR. This agreement has no preferential terms .

Item (30): Approval on business and contracts concluded between the company and a Tadawy company for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 70,592 SR. This agreement has no Preferential terms.

Item (31): Approval on business and contracts concluded between the company and Al-Huwaish Company, for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 1,161,319 SR. This agreement has no preferential terms.

Item (32): Approval on the business and contracts that will take place between the company and the Saudi Electronic Computer Company (SBM Ltd) in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a contract for providing computer equipment, licenses, and other things knowing that the business during The year 2019 amounted to 421 thousand SR. This agreement has no preferential terms.

Item (33): Approval on the business and contracts that will take place between the company and Lonsdale and Associates Insurance Brokerage Company, in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a contract for providing insurance brokerage services, knowing that the business during the year 2019 amounted to 132 thousand SR. This agreement has no preferential terms.

Item (34): Approval on the business and contracts that will take place between the company and the Suleiman Fakeeh Hospital Company and the Fakeeh Clinic, which a member of the board of directors Dr.

Mazen Suleiman Fakeeh has an indirect interest in, which is a contract for providing health services to the

(6)

Page 6 of 6

insured, knowing that the business during the year 2019 amounted to 4,353,000 million SR. This agreement has no preferential terms.

Item (35): Approval on the business and contracts that will take place between the company and the International Medical Hospital Company and for which a member of the Board of Directors Mr. Faisal Farouk Tamer has an indirect interest in it, which is a contract for providing health services to the insured, knowing that the business during the year 2019 amounted to 2,204,000 million SR . This agreement has no preferential terms.

Referensi

Dokumen terkait

Announces the Result of the Shareholder Ordinary Assembly Meeting First Meeting 1- The Board of Directors report for the fiscal year ending on 31-12-2022 was viewed and discussed.. 3-

9- To vote on a feed purchase contract at the prevailing commercial terms between Almarai Company and Al Kabeer Farms in which HH Prince Sultan bin Mohammed bin Saud Al Kabeer, Chairman

It consists of a rental contract for Riyad bank HQ building Granada Oasis in Riyadh, the value of this transaction reached in 2022 SAR 31,068,444 without preferential terms in addition

Khaled Abdel Jalil Batterjee have indirect interest in it, The nature of Transaction is Administrative supervision agreement for the Saudi German Hospital in Cairo- Egypt in exchange

BOARD REPORT OF THE FINANCIAL YEAR 2022 2 Annual Board Report of Al Yamamah Steel Industries Company For the Fiscal Year Ended September 30, 2022 To the respected shareholders of

BOARD ACTION 40 CONFIRMED the Memorandum of Agreement between the University of the Philippines and the Philippine Council for Health Research and Development PCHRD Project:

23 CONFIRMED the Contract of Services between the University of the Philippines and the Department of Budget and Management Project: Renovation of Arcache Building Building IV and

PAKAR – Good Corporate Governance of PT Bank Central Asia Tbk Version Date: 30 June 2021 4/8 Charter for the Board of Directors, Continuation Obligations, Duties,